By Matt Grossman

 

Danaher Corp. on Thursday logged greater sales and earnings in the third quarter, including contributions from its work on Covid-19 testing and countermeasures.

The medical and diagnostics company posted earnings of $1.54 a share, up from $1.16 a share a year earlier. Net income was $1.12 billion, up from $842 billion a year ago.

Stripping out one-time items, the company posted earnings of $2.39 a share. Analysts were forecasting adjusted earnings of $2.15 a share, according to FactSet.

Danaher's sales were $7.23 billion, up from $5.88 billion in the year-ago quarter. Analysts had anticipated revenue of $7 billion.

Covid-19-related tailwinds boosted sales by 10.5% in the quarter. Excluding that and the effects of acquisitions and currency exchange, base-business core sales growth was 10% year-over-year, the company said.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

October 21, 2021 06:28 ET (10:28 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Danaher (NYSE:DHR)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Danaher Charts.
Danaher (NYSE:DHR)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Danaher Charts.